Wang ZH - Search Results

1

[Efficacy of short-term and intensive chemotherapy for the treatment of childhood and adolescent B cell non-Hodgkin's lymphoma].

Sun XF, Liu DG, Zhen ZJ, Chen XQ, Xia Y, Wang ZH, He YJ, Guan ZG. Sun XF, et al. Among authors: wang zh. Zhonghua Xue Ye Xue Za Zhi. 2005 Oct;26(10):581-4. Zhonghua Xue Ye Xue Za Zhi. 2005. PMID: 16532964 Chinese.

2

[Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients].

Xia Y, Sun XF, Zhang CQ, Zhen ZJ, Wang ZH, Wang ZQ. Xia Y, et al. Among authors: wang zh, wang zq. Ai Zheng. 2004 Nov;23(11 Suppl):1448-50. Ai Zheng. 2004. PMID: 15566654 Chinese.

3

[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].

Zhen ZJ, Sun XF, Xia Y, Wang ZH, Ling JY. Zhen ZJ, et al. Among authors: wang zh. Ai Zheng. 2006 Apr;25(4):471-5. Ai Zheng. 2006. PMID: 16613683 Chinese.

4

Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.

Sun XF, Zhen ZJ, Lui DG, Xia Y, He YJ, Wang ZH, Lin JY, Guan ZZ. Sun XF, et al. Among authors: wang zh. Eur J Haematol. 2006 Nov;77(5):365-71. doi: 10.1111/j.1600-0609.2006.00735.x. Epub 2006 Jul 27. Eur J Haematol. 2006. PMID: 16879606 Clinical Trial.

5

[Efficacy of chemotherapy regimen using ifosphamide and carboplatin on recurrent or refractory neuroblastoma].

Zhen ZJ, Sun XF, Xia Y, Wang ZH, Ling JY. Zhen ZJ, et al. Among authors: wang zh. Ai Zheng. 2006 Dec;25(12):1550-2. Ai Zheng. 2006. PMID: 17166384 Chinese.

6

[The clinical features of B cell lymphoblastic lymphoma and outcomes after BFM-90 regimen therapy].

Sun XF, Zhen ZJ, Xia Y, Yang QY, Wang ZH, Ling JY. Sun XF, et al. Among authors: wang zh. Zhonghua Xue Ye Xue Za Zhi. 2006 Oct;27(10):649-52. Zhonghua Xue Ye Xue Za Zhi. 2006. PMID: 17343193 Chinese.

7

First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma.

Wang L, Wang ZH, Chen XQ, Li YJ, Wang KF, Xia YF, Xia ZJ. Wang L, et al. Among authors: wang kf, wang zh. Cancer. 2013 Jan 15;119(2):348-55. doi: 10.1002/cncr.27752. Epub 2012 Jul 18. Cancer. 2013. PMID: 22811078 Free article.

8

Long-term outcomes of modified Berlin-Frankfurt-Münster-90 regimen in adults with T-lymphoblastic lymphoma: a single-center experience.

Wang K, Chen X, Wuxiao Z, Wang Z, Sun X, Zeng Z, Li S, Xia ZJ. Wang K, et al. Leuk Lymphoma. 2014 Aug;55(8):1800-5. doi: 10.3109/10428194.2013.828350. Epub 2014 Mar 7. Leuk Lymphoma. 2014. PMID: 24475787

9

Comparison of gemcitabine, oxaliplatin and L-asparaginase and etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone as first-line chemotherapy in patients with stage IE to IIE extranodal natural killer/T-cell lymphoma: a multicenter retrospective study.

Wang H, Wuxiao ZJ, Zhu J, Wang Z, Wang KF, Li S, Chen X, Lu Y, Xia ZJ. Wang H, et al. Leuk Lymphoma. 2015 Apr;56(4):971-7. doi: 10.3109/10428194.2014.939964. Epub 2014 Aug 20. Leuk Lymphoma. 2015. PMID: 24991715

10

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma.

Peng PJ, Lv BJ, Tang C, Liao H, Lin Z, Liu YM, Wang ZH, Wang SY, Cheng ZB. Peng PJ, et al. Among authors: wang zh, wang sy. Drug Des Devel Ther. 2015 Dec 10;9:6401-5. doi: 10.2147/DDDT.S95946. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26677316 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,573 results

Search Page

Filters